Head-to-head dispatch
OurView Health vs Ozari Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.
Marked down on: A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
Desk Score
Ozari Health is a telehealth weight-loss platform selling physician-prescribed compounded GLP-1 from licensed 503A/503B pharmacies.
Marked down on: The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
Ozari Health takes this head-to-head with the higher Desk Score, 73/100 (C) against 61/100 (C) for OurView Health. OurView Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
OurView Health
61/100
C
Ozari Health
73/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | OurView Health | Ozari Health |
|---|---|---|
| Semaglutide | $75/mo (starting dose, compounded) | $86/mo (3-mo starter plan, new patients only, compounded) |
| Tirzepatide | $135/mo (starting dose, compounded) | $125/mo (3-mo starter plan, new patients only, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want budget shoppers wanting low-cost compounded GLP-1 via a membership savings model. | Readers who want budget-focused patients wanting LegitScript-certified compounded GLP-1 from as low as $86/month. |
| Desk Score | 61/100C | 73/100C |
The verdict
Desk pick — Ozari HealthOzari Health takes this head-to-head with the higher Desk Score, 73/100 (C) against 61/100 (C) for OurView Health. OurView Health still holds its ground where its strengths line up with yours.
Choose OurView Health if…
Readers who want budget shoppers wanting low-cost compounded GLP-1 via a membership savings model.
$75/mo (starting dose, compounded) sema · $135/mo (starting dose, compounded) tirz · Coverage not published
Choose Ozari Health if…
Readers who want budget-focused patients wanting LegitScript-certified compounded GLP-1 from as low as $86/month.
$86/mo (3-mo starter plan, new patients only, compounded) sema · $125/mo (3-mo starter plan, new patients only, compounded) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: OurView Health · Ozari Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- OurView Health vs CoreAge Rx
- Ozari Health vs Vaylen
- OurView Health vs Strut Health
- Ozari Health vs Ondra Health
- OurView Health vs Invigor Medical
- Ozari Health vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.